Ultragenyx Pharmaceutical Inc. (RARE)

Last Closing Price: 17.22 (2026-11-19)

Free Cash Flow per Share (Quarterly)

Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)

Ultragenyx Pharmaceutical Inc. (RARE) had Free Cash Flow per Share of $-3.34 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$173.00M
$-118.00M
$32.00M
$141.00M
$283.00M
$-110.00M
$-17.00M
$-127.00M
$-127.00M
$-118.00M
$-118.00M
$-118.00M
$-118.00M
$-110.00M
$-101.00M
102.10M
102.10M
$-1.16
$-1.16
Balance Sheet Financials
$544.00M
$231.00M
$643.00M
$1.19B
$389.00M
--
$1.17B
$1.56B
$-376.00M
$-590.00M
$-376.00M
101.90M
Cash Flow Statement Financials
$-337.00M
$53.00M
$13.00M
$436.00M
$164.00M
$-272.00M
$98.00M
--
--
Fundamental Metrics & Ratios
1.40
--
--
--
--
81.50%
-63.58%
-63.58%
--
-73.41%
-68.21%
$-341.00M
--
--
--
0.15
0.54
1.04
86.36
31.38%
20.00%
-9.94%
31.38%
$-3.69
Free Cash Flow per Share
$-3.34
$-3.30